Iceni Diagnostics is located in offices and laboratories within the Norwich Research Park Innovation Centre. With the close proximity of the cluster of complementary academic and research institutions on the park, Iceni Diagnostics has immediate access to a wealth of additional expertise and state-of-the-art platform technologies.
Founders Rob Field PhD and David Russell PhD have more than 50 years’ experience in academic and translational research, including at a senior scientific and managerial level. They have worked together closely for 15 years on the development of new methods in carbohydrate and analytical chemistry, with a focus on carbohydrate recognition in the context of detection, quantitation and therapeutic impact.
The management team
Dr Berwyn Clarke
The Iceni Diagnostics management team is chaired by Berwyn Clarke PhD, who has over 25 years’ experience in diagnostics and pharmaceuticals, in both start-ups and global businesses such as GlaxoWellcome and Bayer Diagnostics. Founder of Lab21, Dr Clarke has established two companies to commercialise new intellectual property and he is currently CEO of Glyconics Ltd, Chairman of the Board of NALIA Systems Ltd, and Non-Executive Director of Protein Logic Ltd.
Professor Rob Field
Co-founder and CEO
Rob Field is a project leader at the BBSRC-supported John Innes Centre and Honorary Professor of Chemistry at UEA. He has worked in carbohydrate chemistry and biochemistry for more than 25 years, publishing more than 180 research papers and review articles and delivering more than 190 research lectures. Professor Field’s research concerns many aspects of the chemical and enzymatic synthesis of glycoconjugates, as well as their utilisation in structural and biochemical analyses.
Professor David Russell
Co-founder and CSO
David Russell is an emeritus Professor of Chemistry at the University of East Anglia. The research of his group was focused within bioanalytical chemistry. He has published more than 100 research papers and delivered more than 50 plenary, keynote and invited research lectures over the past ten years. His research focused on the stabilisation of metal nanoparticles: with carbohydrates for the detection of toxins, bacteria and viruses; with antibodies and proteins for the detection of drugs and drug metabolites; and to deliver light-activated photosensitisers for PDT cancer therapy. In 2007 Professor Russell founded, and is currently CSO of, Intelligent Fingerprinting Ltd.
Dr. Jonathan Clarke
Non Executive Director
Jon Clarke is the Head of Business Development at the John Innes Centre (JIC). He worked in plant and microbial functional genomics for 25 years before establishing Knowledge Exchange and Commercialisation at the JIC. He has experience in company formation having created five JIC spinout companies since 2014 and in 2016 led JIC to win the BBSRC’s Excellence with Impact competition. He brings experience in company bio-incubation and has worked closely with Innovate UK, UKTI and regional development agencies.